Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders

Elizabeth K. Nousen, Juliana G. Franco, Elinor Sullivan

    Research output: Contribution to journalArticle

    43 Citations (Scopus)

    Abstract

    The increased prevalence and high comorbidity of metabolic syndrome (MetS) and mental health disorders (MHDs) have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between MetS and MHDs including schizophrenia, bipolar disorder, depression, anxiety, attention-deficit/hyperactivity disorder, and autism spectrum disorders. Medication side effects and social repercussions are contributing environmental factors, but there are a number of shared underlying neurological and physiological mechanisms that explain the high comorbidity between these two disorders. Inflammation is a state shared by both disorders, and it contributes to disruptions of neuroregulatory systems (including the serotonergic, dopaminergic, and neuropeptide Y systems) as well as dysregulation of the hypothalamic-pituitary-adrenal axis. MetS in pregnant women also exposes the developing fetal brain to inflammatory factors that predispose the offspring to MetS and psychopathologies. Due to the shared nature of these conditions, treatment should address aspects of both mental health and metabolic disorders. Additionally, interventions that can interrupt the transfer of increased risk of the disorders to the next generation need to be developed.

    Original languageEnglish (US)
    Pages (from-to)254-266
    Number of pages13
    JournalNeuroendocrinology
    Volume98
    Issue number4
    DOIs
    StatePublished - 2014

    Fingerprint

    Mental Disorders
    Comorbidity
    Mental Health
    Bipolar Disorder
    Neuropeptide Y
    Attention Deficit Disorder with Hyperactivity
    Psychopathology
    Pregnant Women
    Schizophrenia
    Anxiety
    Inflammation
    Brain
    Therapeutics

    Keywords

    • Bipolar disorder
    • Depression
    • Diabetes
    • Metabolic syndrome
    • Obesity
    • Schizophrenia

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism
    • Endocrine and Autonomic Systems
    • Cellular and Molecular Neuroscience
    • Medicine(all)

    Cite this

    Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders. / Nousen, Elizabeth K.; Franco, Juliana G.; Sullivan, Elinor.

    In: Neuroendocrinology, Vol. 98, No. 4, 2014, p. 254-266.

    Research output: Contribution to journalArticle

    @article{a2d98cb8ad104579ba31b0fbce22034f,
    title = "Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders",
    abstract = "The increased prevalence and high comorbidity of metabolic syndrome (MetS) and mental health disorders (MHDs) have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between MetS and MHDs including schizophrenia, bipolar disorder, depression, anxiety, attention-deficit/hyperactivity disorder, and autism spectrum disorders. Medication side effects and social repercussions are contributing environmental factors, but there are a number of shared underlying neurological and physiological mechanisms that explain the high comorbidity between these two disorders. Inflammation is a state shared by both disorders, and it contributes to disruptions of neuroregulatory systems (including the serotonergic, dopaminergic, and neuropeptide Y systems) as well as dysregulation of the hypothalamic-pituitary-adrenal axis. MetS in pregnant women also exposes the developing fetal brain to inflammatory factors that predispose the offspring to MetS and psychopathologies. Due to the shared nature of these conditions, treatment should address aspects of both mental health and metabolic disorders. Additionally, interventions that can interrupt the transfer of increased risk of the disorders to the next generation need to be developed.",
    keywords = "Bipolar disorder, Depression, Diabetes, Metabolic syndrome, Obesity, Schizophrenia",
    author = "Nousen, {Elizabeth K.} and Franco, {Juliana G.} and Elinor Sullivan",
    year = "2014",
    doi = "10.1159/000355632",
    language = "English (US)",
    volume = "98",
    pages = "254--266",
    journal = "Neuroendocrinology",
    issn = "0028-3835",
    publisher = "S. Karger AG",
    number = "4",

    }

    TY - JOUR

    T1 - Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders

    AU - Nousen, Elizabeth K.

    AU - Franco, Juliana G.

    AU - Sullivan, Elinor

    PY - 2014

    Y1 - 2014

    N2 - The increased prevalence and high comorbidity of metabolic syndrome (MetS) and mental health disorders (MHDs) have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between MetS and MHDs including schizophrenia, bipolar disorder, depression, anxiety, attention-deficit/hyperactivity disorder, and autism spectrum disorders. Medication side effects and social repercussions are contributing environmental factors, but there are a number of shared underlying neurological and physiological mechanisms that explain the high comorbidity between these two disorders. Inflammation is a state shared by both disorders, and it contributes to disruptions of neuroregulatory systems (including the serotonergic, dopaminergic, and neuropeptide Y systems) as well as dysregulation of the hypothalamic-pituitary-adrenal axis. MetS in pregnant women also exposes the developing fetal brain to inflammatory factors that predispose the offspring to MetS and psychopathologies. Due to the shared nature of these conditions, treatment should address aspects of both mental health and metabolic disorders. Additionally, interventions that can interrupt the transfer of increased risk of the disorders to the next generation need to be developed.

    AB - The increased prevalence and high comorbidity of metabolic syndrome (MetS) and mental health disorders (MHDs) have prompted investigation into the potential contributing mechanisms. There is a bidirectional association between MetS and MHDs including schizophrenia, bipolar disorder, depression, anxiety, attention-deficit/hyperactivity disorder, and autism spectrum disorders. Medication side effects and social repercussions are contributing environmental factors, but there are a number of shared underlying neurological and physiological mechanisms that explain the high comorbidity between these two disorders. Inflammation is a state shared by both disorders, and it contributes to disruptions of neuroregulatory systems (including the serotonergic, dopaminergic, and neuropeptide Y systems) as well as dysregulation of the hypothalamic-pituitary-adrenal axis. MetS in pregnant women also exposes the developing fetal brain to inflammatory factors that predispose the offspring to MetS and psychopathologies. Due to the shared nature of these conditions, treatment should address aspects of both mental health and metabolic disorders. Additionally, interventions that can interrupt the transfer of increased risk of the disorders to the next generation need to be developed.

    KW - Bipolar disorder

    KW - Depression

    KW - Diabetes

    KW - Metabolic syndrome

    KW - Obesity

    KW - Schizophrenia

    UR - http://www.scopus.com/inward/record.url?scp=84896490774&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84896490774&partnerID=8YFLogxK

    U2 - 10.1159/000355632

    DO - 10.1159/000355632

    M3 - Article

    VL - 98

    SP - 254

    EP - 266

    JO - Neuroendocrinology

    JF - Neuroendocrinology

    SN - 0028-3835

    IS - 4

    ER -